- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CPRX
Recent news which mentions CPRX
Earnings Scheduled For March 15, 2023
March 15, 2023
From Benzinga
7 Core Stocks to Build a Solid Portfolio Around
March 13, 2023
From InvestorPlace
2 Growth Stocks to Invest $1,000 in Right Now
March 03, 2023
From Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
March 03, 2023
From Motley Fool
7 Smart Stock Picks for Cautious Investors
February 28, 2023
From InvestorPlace
The 7 Best Growth Stocks to Buy for February 2023
February 06, 2023
From InvestorPlace
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
January 26, 2023
From Motley Fool
Here's How Much $1000 Invested In Catalyst Pharmaceuticals 15 Years Ago Would Be Worth Today
January 25, 2023
Tickers
CPRX
From Benzinga
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher
January 23, 2023
From Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
From Benzinga
Dow Jumps Over 300 Points; Crude Oil Up 1%
January 23, 2023
From Benzinga
From Benzinga
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
January 23, 2023
From Benzinga
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
January 23, 2023
From Benzinga
Analyst Expectations for Catalyst Pharmaceuticals's Future
January 19, 2023
Tickers
CPRX
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Catalyst Pharmaceuticals: Here's What You Need To Know
December 21, 2022
Tickers
CPRX
From Benzinga
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
From Benzinga
This Growth Stock's Jaw-Dropping Run-Up Is Smashing Tesla's
December 16, 2022
From Motley Fool
Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday
November 22, 2022
From Benzinga
These 3 Stocks Are Winning the Bear Market -- Here's How
October 21, 2022
From Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less Than $15
September 28, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.